(Alliance News) - GSK PLC on Thursday said its monoclonal antibody Nucala, also known as mepolizumab, has been accepted for review in China.

A 30-year-old woman from New England contracted brain worms during a vacation to Hawaii, Thailand, and Japan. Her symptoms ...

Mepolizumab reduces asthma exacerbations among real-world patients with severe asthma and an eosinophilic phenotype.

An expert review provides best practice advice on diagnostic considerations of immune-mediated disorders that should be ...

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

Researchers are tackling neutrophilic asthma, successfully developing one of the first mouse models of the condition.

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025Priority ...

A young American woman who travelled to Thailand, Japan, and Hawaii complained of a severe burning sensation in her feet, ...

A WOMAN who complained of a burning sensation in her feet after returning home from a trip abroad was revealed to have parasitic worms in her brain. The 30-year-old woman had just returned from a ...

Severe eosinophilic is effectively treated with benralizumab, with especially good outcomes in patients with high BEC and high FeNO.

The American Academy of Allergy, Asthma & Immunology/World Allergy Organization Joint Congress will be held Feb. 28 to March ...